DELX (Delex Healthcare Group) Research & Development: $ Mil (TTM As of Sep. 2023)


What is Delex Healthcare Group Research & Development?

Delex Healthcare Group DELX Research & Development is $ Mil as of Sep. 2023.

Research & Development is the aggregate amount of research and development expenses during the year. Delex Healthcare Group's Research & Development for the six months ended in Sep. 2023 was $0.00 Mil. Delex Healthcare Group does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Sep. 2023.

Delex Healthcare Group  (OTCPK:DELX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Delex Healthcare Group Research & Development Related Terms

Delex Healthcare Group Research & Development Historical Data

* Premium members only.

The historical data trend for Delex Healthcare Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delex Healthcare Group Research & Development Chart

Delex Healthcare Group Annual Data
Trend
Research & Development

Delex Healthcare Group Semi-Annual Data
Sep22 Sep23
Research & Development 0.00 0.00

Delex Healthcare Group Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $ Mil mean?
Delex Healthcare Group (DELX) has a Research & Development of $ Mil as of Sep. 2023. Research and development expense is the total cost for research and development activities. View historical data on Delex Healthcare Group and its competitors.
Is Delex Healthcare Group's Research & Development too high?
Delex Healthcare Group's current Research & Development is $ Mil.
How does Delex Healthcare Group's Research & Development compare to PIAC and PWM?
Delex Healthcare Group's Research & Development of $ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Delex Healthcare Group and its competitors. Delex Healthcare Group's current Research & Development is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delex Healthcare Group stock overvalued right now?
Delex Healthcare Group (DELX) has a current Research & Development of $ Mil. The current Research & Development is $ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Delex Healthcare Group (DELX), the current Research & Development is $ Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Delex Healthcare Group Business Description

Address Carnation Street, Blk 4, Lot 4, Cor., Magnolia, Novaliches, Quezon City, PHL, 1109
Delex Healthcare Group Inc is a healthcare-focused organization engaged in pharmaceutical and healthcare-related businesses.